SU788471A1 - Психотропное средство дл лечени депрессивных состо ний "инказан - Google Patents
Психотропное средство дл лечени депрессивных состо ний "инказан Download PDFInfo
- Publication number
- SU788471A1 SU788471A1 SU721850615A SU1850615A SU788471A1 SU 788471 A1 SU788471 A1 SU 788471A1 SU 721850615 A SU721850615 A SU 721850615A SU 1850615 A SU1850615 A SU 1850615A SU 788471 A1 SU788471 A1 SU 788471A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- preparations
- inkazan
- depressive states
- psychotropic agent
- treating depressive
- Prior art date
Links
- 208000020401 Depressive disease Diseases 0.000 title 1
- GVXBHSBKKJRBMS-UHFFFAOYSA-N metralindole Chemical compound C1CN(C)C2=NCCC3=C2N1C1=CC=C(OC)C=C13 GVXBHSBKKJRBMS-UHFFFAOYSA-N 0.000 title 1
- 239000004089 psychotropic agent Substances 0.000 title 1
- 239000000935 antidepressant agent Substances 0.000 abstract description 3
- 229940005513 antidepressants Drugs 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract 2
- KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- -1 linctuses Substances 0.000 abstract 1
- 239000007937 lozenge Substances 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 241000976924 Inca Species 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU721850615A SU788471A1 (ru) | 1972-11-28 | 1972-11-28 | Психотропное средство дл лечени депрессивных состо ний "инказан |
| DE2356091A DE2356091A1 (de) | 1972-11-28 | 1973-11-09 | Heilmittel mit psychotroper wirkung |
| FR7342414A FR2207727B1 (enExample) | 1972-11-28 | 1973-11-28 | |
| GB5522473A GB1444980A (en) | 1972-11-28 | 1973-11-28 | Psychotropic medicinal preparation |
| US05/557,189 US3959470A (en) | 1972-11-28 | 1975-03-10 | Psychotropic medicinal preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU721850615A SU788471A1 (ru) | 1972-11-28 | 1972-11-28 | Психотропное средство дл лечени депрессивных состо ний "инказан |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU788471A1 true SU788471A1 (ru) | 1981-12-30 |
Family
ID=20533240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU721850615A SU788471A1 (ru) | 1972-11-28 | 1972-11-28 | Психотропное средство дл лечени депрессивных состо ний "инказан |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE2356091A1 (enExample) |
| FR (1) | FR2207727B1 (enExample) |
| GB (1) | GB1444980A (enExample) |
| SU (1) | SU788471A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7872133B2 (en) | 2003-06-23 | 2011-01-18 | Ono Pharmaceutical Co., Ltd. | Tricyclic heterocycle compound |
| US7964726B2 (en) | 2004-12-22 | 2011-06-21 | Ono Pharmaceutical Co., Ltd. | Tricyclic compound and use thereof |
-
1972
- 1972-11-28 SU SU721850615A patent/SU788471A1/ru active
-
1973
- 1973-11-09 DE DE2356091A patent/DE2356091A1/de active Pending
- 1973-11-28 FR FR7342414A patent/FR2207727B1/fr not_active Expired
- 1973-11-28 GB GB5522473A patent/GB1444980A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1444980A (en) | 1976-08-04 |
| FR2207727B1 (enExample) | 1977-09-02 |
| DE2356091A1 (de) | 1974-07-04 |
| FR2207727A1 (enExample) | 1974-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Meyer et al. | The antirheumatic effect of sodium gentisate | |
| IT9020562A1 (it) | Agente antitussivo e mucoregolatore, sua preparazione e composizioni farmaceutiche | |
| SE8400332L (sv) | Forening for anvendning som mellanprodukt vid framstellning av lekemedel | |
| SU788471A1 (ru) | Психотропное средство дл лечени депрессивных состо ний "инказан | |
| Similá et al. | Oral antipyretic therapy: evaluation of ibuprofen | |
| Buscaglia et al. | Pulmonary infiltrates associated with naproxen | |
| Bowers et al. | Central monoamine oxidase inhibition and REM sleep. | |
| STEIN | Further observations on the treatment of superficial thrombophlebitis with phenylbutazone (butazolidin) | |
| GB1291559A (en) | N-(4-chlorocinnamoyl)-4-hydroxypiperidine | |
| GB1154454A (en) | New Anthranilic Acid Derivatives | |
| GB1415228A (en) | Pharmacologically active acetic acid derivatives | |
| Barowsky et al. | A new approach to the management of peptic ulcer by inducing sustained gastric inactivity. | |
| CA2503212A1 (fr) | Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien | |
| SU1261670A1 (ru) | Способ лечени больных хроническим фурункулезом | |
| Komurcugil et al. | A Case of Steven-Johnson Syndrome: Favipiravir induced or Covid-19 disease related? | |
| BE800284A (en) | Indan carboxylic acid derivs compsns - for treatment of allergies | |
| GB1327468A (en) | Pharmaceutical compositions for inhibiting indoleamine n-methyl transferase | |
| McCleave | Dysmenorrhea | |
| SE320076B (enExample) | ||
| Chatterjee et al. | Possible Therapeutic Value of Drug Induced Side Reactions | |
| BUNTING et al. | Toxic Reactions of Sulfaguanidine Therapy | |
| KANTER et al. | Treatment of dermatitis herpetiformis resistant to usual therapy | |
| RU1836951C (ru) | Противо звенное средство | |
| Adams et al. | Studies on Synthetic Antimalarial Drugs: VI.—A Comparison of the Therapeutic Actions of 3349 and of Mepacrine Hydrochloride on Acute Attacks of Benign Tertian Malaria | |
| ES406329A1 (es) | Procedimiento de preparacion de nuevos derivados del acido fenilacetico. |